Search by Drug Name or NDC

    NDC 17478-0305-11 Olopatadine 2 mg/mL Details

    Olopatadine 2 mg/mL

    Olopatadine is a OPHTHALMIC SOLUTION/ DROPS in the HUMAN OTC DRUG category. It is labeled and distributed by Akorn. The primary component is OLOPATADINE HYDROCHLORIDE.

    Product Information

    NDC 17478-0305
    Product ID 17478-305_4df9962a-31a1-454d-9e4a-a86927409e5e
    Associated GPIs 86802065102030
    GCN Sequence Number 062065
    GCN Sequence Number Description olopatadine HCl DROPS 0.2 % OPHTHALMIC
    HIC3 Q6R
    HIC3 Description EYE ANTIHISTAMINES
    GCN 97848
    HICL Sequence Number 012815
    HICL Sequence Number Description OLOPATADINE HCL
    Brand/Generic Generic
    Proprietary Name Olopatadine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Olopatadine Hydrochloride
    Product Type HUMAN OTC DRUG
    Dosage Form SOLUTION/ DROPS
    Route OPHTHALMIC
    Active Ingredient Strength 2
    Active Ingredient Units mg/mL
    Substance Name OLOPATADINE HYDROCHLORIDE
    Labeler Name Akorn
    Pharmaceutical Class Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA204723
    Listing Certified Through 2023-12-31

    Package

    NDC 17478-0305-11 (17478030511)

    NDC Package Code 17478-305-11
    Billing NDC 17478030511
    Package 2 BOTTLE, DROPPER in 1 CARTON (17478-305-11) / 2.5 mL in 1 BOTTLE, DROPPER
    Marketing Start Date 2021-09-01
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 138f0f62-c5d2-457c-8a29-c44fd84aefde Details

    Revised: 2/2022